Engineering H5N1 avian influenza viruses to study human adaptation

Nature

Volumn 486, Issue 7403, 2012, Pages 335-340

  Morens, David M ^a   Subbarao, Kanta ^a   Taubenberger, Jeffery K ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA; DISEASE TRANSMISSION; GENETIC ENGINEERING; MUSTELID;

ADAPTATION; BIOSAFETY; FERRET; GENETIC ENGINEERING; HUMAN; INFLUENZA VIRUS A H5N1; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; UNITED STATES; VIRUS MUTANT; VIRUS MUTATION; VIRUS TRANSMISSION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIOTERRORISM; GENETIC ENGINEERING; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; PUBLISHING; SECURITY MEASURES; ZOONOSES;

EID: 84862574706     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11170     Document Type: Review

References (102)

1. Imai, M. et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmissionto a reassortantH5HA/H1N1virus in ferrets.Nature http://dx.doi.org/10.1038/nature10831 (this issue).
2. Herfst, S. et al. Aerosol transmission of avian influenza A/H5N1 virus. Science (22 June 2012).
3. Doherty, P. C.&Thomas, P. G.Dangerous for ferrets: lethal for humans?BMCBiol. 10, 10 (2012).
4. Fouchier, R. et al. Preventing pandemics: the fight over flu. Nature 481, 257-259 (2012).
5. Osterholm, M. T. & Kelley, N. S. Mammalian-transmissible H5N1 influenza: facts and perspective. MBio 3, 2 (2012).
6. Palese, P. Don't censor life-saving science. Nature 481, 115 (2012).
7. Webster, R. G. Mammalian-transmissible H5N1 influenza: the dilemma of dual-use research. MBio 3, 1 (2012).
8. Parrish, C. R. et al. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72, 457-470 (2008).
9. WHO. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. http://www.who.int/influenza/human-animal-interface/ H5N1-cumulative-table-archives/en/index.html (2012).
10. Taubenberger, J. K. & Kash, J. C. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7, 440-451 (2010).
11. Brown, T. H5N1 research discussed in special session at ASM. http://www.medscape.com/viewarticle/759465 (2012).
12. Fouchier, R. A. et al. Pause on avian flu transmission research. Science 335, 400-401 (2012).
13. Kawaoka, Y. H5N1: Flu transmission work is urgent. Nature 482, 155 (2012).
14. Osterholm, M. T., Fauci, A. S., Alberts, B. & Fouchier, R. A. M. Discussion of NSABB's publication recommendations for the NIH-funded research on the transmissibility of H5N1. http://www.asmbiodefense.org/index.php/ programinformation/nsabbs-recommendations-for-h5n1-research (2012).
15. Kawaoka, Y. & Fouchier, R. A. Royal Society meeting. H5N1 research: biosafety, biosecurityandbioethics. http://royalsociety.org/events/2012/viruses/ (2012).
16. Wilson, H. E., Saslaw, S., Doan, C. A., Woolpert, O. C. & Schwab, J. L. Reactions of monkeys to experimental mixed influenza and Streptococcus infections: an analysis of the relative roles of humoral and cellular immunity, with the description of an intercurrent nephritic syndrome. J. Exp. Med. 85, 199-215 (1947).
17. Swayne, D. E. Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis. 51, 242-249 (2007). (Pubitemid 46671286)
18. Francis, T. Jr. Influenza: the new acquayantance. Ann. Intern. Med. 39, 203-221 (1953).
19. Masurel, N. & Marine, W. M. Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man. Am. J. Epidemiol. 97, 44-49 (1973).
20. Hilleman, M. R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20, 3068-3087 (2002).
21. Morens, D. M., Taubenberger, J. K.&Fauci, A. S. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 361, 225-229 (2009).
22. Bogs, J. et al. Reversion of PB2-627E to-627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J. Virol. 85, 10691-10698 (2011).
23. Chen, H. et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J. Virol. 80, 5976-5983 (2006). (Pubitemid 43849175)
24. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842 (2001). (Pubitemid 32845783)
25. Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410 (2006).
26. Yen, H. L. et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol. 81, 6890-6898 (2007).
27. Memoli, M. J. et al. An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 393, 338-345 (2009).
28. Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. & Huggins, J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178, 651-661 (1998). (Pubitemid 28397211)
29. Bray, M., Hatfill, S., Hensley, L. & Huggins, J. W. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouseadapted variant of Ebola Zaire virus. J. Comp. Pathol. 125, 243-253 (2001). (Pubitemid 34023737)
30. Chen, G. L. et al. Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets. J. Virol. 84, 7695-7702 (2010).
31. Hinshaw, V.S.,Webster, R. G., Easterday, B. C.&Bean, W. J. Jr. Replication of avian influenza A viruses in mammals. Infect. Immun. 34, 354-361 (1981). (Pubitemid 12117530)
32. Joseph, T. et al. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J. Virol. 81, 10558-10566 (2007). (Pubitemid 47463329)
33. Song, H., Wan, H., Araya, Y. & Perez, D. R. Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol. J. 6, 126 (2009).
34. Beare, A. S. & Webster, R. G. Replication of avian influenza viruses in humans. Arch. Virol. 119, 37-42 (1991).
35. Belser, J. A., Katz, J. M. & Tumpey, T. M. The ferret as a model organism to study influenza A virus infection. Dis. Model Mech. 4, 575-579 (2011).
36. Tumpey, T. M. et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315, 655-659 (2007). (Pubitemid 46214711)
37. Van Hoeven, N. et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl Acad. Sci. USA 106, 3366-3371 (2009).
38. Watanabe, T. et al. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc. Natl Acad. Sci. USA 106, 588-592 (2009).
39. Kimble, J. B., Sorrell, E.,Shao, H.,Martin, P. L.&Perez, D. R. Compatibility ofH9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc. Natl Acad. Sci. USA 108, 12084-12088 (2011).
40. Sorrell, E. M., Wan, H., Araya, Y., Song, H. & Perez, D. R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl Acad. Sci. USA 106, 7565-7570 (2009).
41. Koster, F. et al. Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret. PLoS ONE 7, e33118 (2012).
42. Yamanaka, T. et al. No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8). Acta Vet. Scand. 54, 25 (2012).
43. Mänz, B., Brunotte, L., Reuther, P. & Schwemmle, M. Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nature Commun. 3, 802 (2012).
44. Lakdawala, S. S. et al. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 7, e1002443 (2011).
45. Chen, Y. et al. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch. Virol. 154, 227-233 (2009).
46. Govorkova, E. A. et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79, 2191-2198 (2005). (Pubitemid 40204576)
47. Maines, T. R. et al.Avian influenza (H5N1) viruses isolated fromhumans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79, 11788-11800 (2005). (Pubitemid 41279297)
48. Morens, D. M. & Taubenberger, J. K. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir. Viruses 4, 327-337 (2010).
49. Myers, K. P., Olsen, C. W. & Gray, G. C. Cases of swine influenza in humans: a review of the literature. Clin. Infect. Dis. 44, 1084-1088 (2007). (Pubitemid 46580277)
50. Shinde, V. et al. Triple-reassortantswine influenzaA (H1) inhumans in theUnited States, 2005-2009. N. Engl. J. Med. 360, 2616-2625 (2009).
51. Zhou, J. et al. Characterization of the H5N1 highly pathogenic avian influenza virus derived from wild pikas in China. J. Virol. 83, 8957-8964 (2009).
52. Morens, D. M. & Taubenberger, J. K. Pandemic influenza: certain uncertainties. Rev. Med. Virol. 21, 262-284 (2011).
53. Morens, D. M., Taubenberger, J. K. & Fauci, A. S. The 2009 H1N1 pandemic influenza virus: what next? MBio 1, 4 (2010).
54. WHO. WHO case definitions for human infections with influenza A(H5N1) virus. http://www.who.int/influenza/resources/documents/case-definition2006-08- 29/en/index.html (2006).
55. Palese, P. & Wang, T. T. H5N1 influenza viruses: facts, not fear. Proc. Natl Acad. Sci. USA 109, 2211-2213 (2012).
56. Wang, T. T., Parides, M. K. & Palese, P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335, 1463 (2012).
57. Aditama, T. Y. et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin. Infect. Dis. 53, 1237-1244 (2011).
58. Aditama, T. Y. et al. Avian influenzaH5N1transmission in households, Indonesia. PLoS ONE 7, e29971 (2012).
59. Roos, R. No sign of missed H5N1 cases in Bangladesh study. http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/ mar1312seroprev.html (2012).
60. Horby, P. et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol. Infect. 138, 1550-1558 (2010).
61. Trammell, R. A. & Toth, L. A. Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev. Mol. Diagn. 8, 515-529 (2008). (Pubitemid 351962094)
62. Zhang, L., Katz, J. M., Gwinn, M., Dowling, N. F. & Khoury, M. J. Systems-based candidate genes for human response to influenza infection. Infect. Genet. Evol. 9, 1148-1157 (2009).
63. Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
64. Brady, R. C. et al. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine 27, 5091-5095 (2009).
65. Katz, J. M. et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J. Infect. Dis. 180, 1763-1770 (1999).
66. Chen, L. M. et al. In vitro evolution of H5N1 avian influenza virus toward humantype receptor specificity. Virology 422, 105-113 (2012).
67. Maines, T. R. et al. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413, 139-147 (2011).
68. Steel, J., Lowen, A. C., Mubareka, S.& Palese, P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5, e1000252 (2009).
69. Ilyushina, N. A., Govorkova, E. A., Gray, T. E., Bovin, N. V. & Webster, R. G. Humanlike receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog. 4, e1000043 (2008).
70. Yamada, S. et al. Haemagglutininmutations responsible for the binding ofH5N1 influenza A viruses to human-type receptors. Nature 444, 378-382 (2006). (Pubitemid 44764114)
71. Yen, H. L. et al. Changes in H5N1influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc. Natl Acad. Sci. USA 106, 286-291 (2009).
72. Rudneva, I. A. et al. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol. 23, 181-187 (2010).
73. Wang, W. et al. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 84, 6570-6577 (2010).
74. Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nature Struct. Mol. Biol. 16, 265-273 (2009).
75. Bogs, J. et al. Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE 5, e11826 (2010).
76. Gohrbandt, S. et al.Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J. Gen. Virol. 92, 51-59 (2011).
77. Suguitan, A. L. Jr et al. Themultibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J. Virol. 86, 2706-2714 (2012).
78. Seo, S. H., Hoffmann, E. & Webster, R. G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Med. 8, 950-954 (2002). (Pubitemid 35033698)
79. Spesock, A. et al. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 85, 7048-7058 (2011).
80. Zielecki, F. et al. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J. Virol. 84, 10708-10718 (2010).
81. MacKenzie, D. Five easy mutations to make bird flu a lethal pandemic. New Sci. http://www.newscientist.com/article/mg21128314.600-five-easy-mutationsto- make-bird-flu-a-lethal-pandemic.html (2011).
82. WHO. Public health, influenza experts agree H5N1 research critical, but extend delay. http://www.who.int/mediacentre/news/releases/2012/h5n1-research- 20120217/en/index.html (2012).
83. NSABB. National Science Advisory Board for Biosecurity Findings and Recommendations March 29-30, 2012. http://oba.od.nih.gov/biosecurity/ biosecurity-documents.html (NSABB, 2012).
84. WHO. Report on technical consultation on H5N1 research issues. http://www.who.int/influenza/human-animal-interface/consensus-points/en/index. html (2012).
85. MacKenzie, D. Censoring flu data could raise bioterror threat. New Sci. http://www.newscientist.com/article/dn21675-censoring-flu-data-could- raisebioterror-threat.html (2012).
86. CDCin Biosafety in Microbiological and Biomedical Laboratories (BMBL) (eds Chosewood, L. C. & Wilson, D. E.) Ch. 8 (Government Printing Office, 2009).
87. National Research Council in Science and Security in a Post 9/11 World: A Report Based on Regional Discussions Between the Science and Security Communities Ch. 4, 57-68 (NAS, 2007).
88. Killingley, B. et al. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect. Dis. 11, 879-886 (2011).
89. Massung, R. F. et al. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366, 748-751 (1993). (Pubitemid 24038516)
90. Marra, M. A. et al. The genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404 (2003). (Pubitemid 36638153)
91. Herlocher, M. L. et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J. Infect. Dis. 190, 1627-1630 (2004). (Pubitemid 39411012)
92. Memoli, M. J. et al. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J. Infect. Dis. 203, 348-357 (2011).
93. Pappas, C. et al. Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS ONE 5, e11158 (2010).
94. Taubenberger, J. K. & Kash, J. C. Insights on influenza pathogenesis from the grave. Virus Res. 162, 2-7 (2011).
95. Taubenberger, J. K. et al. Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889-893 (2005). (Pubitemid 41486764)
96. Tumpey, T. M. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005). (Pubitemid 41434537)
97. Fleishman, S. J. et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816-821 (2011).
98. Kash, J. C. et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443, 578-581 (2006). (Pubitemid 44527293)
99. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319-323 (2007). (Pubitemid 46122819)
100. Pappas, C. et al. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl Acad. Sci. USA 105, 3064-3069 (2008). (Pubitemid 351723668)
101. Qi, L. et al. The ability ofpandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant proteinD binding. Virology 412, 426-434 (2011).
102. Morens, D. M., Taubenberger, J. K., Harvey, H. A. & Memoli, M. J. The 1918 influenza pandemic: lessons for 2009 and the future. Crit. Care Med. 38, e10-e20 (2010).